Should We Move Up the Clock on Preventive Intervention in Marfan's Disease?
Related Experiment Video
Updated: Oct 2, 2026

Minimally Invasive Transverse Aortic Constriction in Mice
Published on: March 14, 2017
1Department of Thoracic and Cardiovascular Surgery, Sanger Heart and Vascular Institute, Carolinas Medical Center, Charlotte, North Carolina, United States.
Abstract:
Gradual dilatation of the ascending aorta is a common phenomenon in patients with Marfan's disease, which often leads to dissection and rupture. It is estimated that around two-thirds of the patients either die or require major surgery before the age of 42 years. In the mirror of the experience of 40 years with aortic wall reinforcement, the author forward the postulate that whenever the ascending aorta of an individual with proven Marfan's disease reaches adult size, that is, approximately 3.5 cm in diameter, the wall of his/her ascending aorta should be reinforced to prevent further expansion.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Aneurysm III: Interprofessional Care

